Comprehensive Dermatologic Drug Therapy-4판

Description:

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th Edition, helps you safely and
effectively treat the skin disorders you`re likely to see in your practice. Dr. Stephen E. Wolverton and new associate
editor Dr. Jashin J. Wu lead a team of global experts to bring you concise, complete guidance on today`s full spectrum
of topical, intralesional, and systemic drugs. You`ll prescribe with confidence thanks to expert coverage of which
drugs
to use, when to use them, and adverse effects to monitor.

Key Features

Includes new drug interaction tables, drug risk profiles, and FDA guidelines, as well as two new appendices that
summarize chapter questions and summarize highest-risk drug interactions.

Covers the best uses for new biologic therapeutics.

Contains new chapters covering medical decision-making principles, PDE-4 and JAK inhibitors, interleukin 17
inhibitors, interleukin 23 inhibitors, additional biologic therapeutics, and hedgehog pathway inhibitors.

Contains quick-access summaries of indications/contraindications, dosage guidelines, drug interactions, drug
monitoring guidelines, adverse effects, and treatment protocols.

Features a highly detailed, disease-specific index, as well as purchase information for major drugs.

Helps you assess your knowledge and prepare for certification or recertification with about 800 review questions
and
answers throughout the book.

Part I. Introduction
1. Basic Principles of Pharmacology
2. Principles for Maximizing the Safety of Dermatologic Drug Therapy
3. Polymorphisms: Why Individual Drug Responses Vary
더보기

Part II. Important Drug Regulatory Issues
6. The FDA Drug Approval Process
7. Pharmacovigilance: Verifying that Drugs Remain Safe
8. Drugs Taken Off the Market: Important Lessons Learned

Part III. Systemic Drugs for Infectious Diseases
9. Systemic Antibacterial Agents
10. Systemic Antifungal Agents
11. Systemic Antiviral Agents
더보기

Part IV. Systemic Immunomodulatory Drugs
13. Systemic Corticosteroids
14. Methotrexate
15. Azathioprine
더보기

Part V. Drugs Used in Conjunction with UV or Visible Light
23. Psoralen Plus Ultraviolet A Photochemotherapy and Other Phototherapy Modalities
24. Extracorporeal Photochemotherapy (Photopheresis)
25. Photodynamic Therapy

Part VI. Biologic Therapeutics
26. Tumor Necrosis Factor Inhibitors
27. Interleukin 12/23 Inhibitors
28. Interleukin 17 Inhibitors
더보기

Part VII. Miscellaneous Systemic Drugs
32. Antihistamines
33. Vasoactive and Antiplatelet Agents
34. Antiandrogens and Androgen Inhibitors
더보기

Part VIII. Topical Drugs for Infectious Diseases
41. Topical Antibacterial Agents
42. Topical Antifungal Agents
43. Topical and Intralesional Antiviral Agents
더보기

Part IX. Topical Immunomodulatory Drugs
45. Topical Corticosteroids
46. Topical Retinoids
47. Topical and Intralesional Chemotherapeutic Agents
더보기

Part X. Miscellaneous Topical Drugs
50. Sunscreens
51. Therapeutic Shampoos
52. α-Hydroxy Acids
더보기

Part XI. Injectable and Mucosal Routes of Drug Administration
58. Local Anesthetics
59. Injectable Dermal and Subcutaneous Fillers
60. Botulinum Toxin Injections
더보기

Part XII. Major Adverse Effects From Systemic Drugs
62. Hepatotoxicity of Dermatologic Drug Therapy
63. Hematologic Toxicity of Drug Therapy
64. Drug-Induced Malignancy
더보기

Part XIII. Special Pharmacology and Therapeutics Topics
68. Informed Consent and Risk Management
69. Compounding in Dermatology